查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844120

定序试剂市场按产品类型、应用、技术、最终用户和平台划分－2025-2032年全球预测

Sequencing Reagents Market by Product Type, Application, Technology, End User, Platform - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，定序试剂市场规模将达到 128 亿美元，复合年增长率为 10.93%。

主要市场统计数据
基准年 2024 55.8亿美元
预计年份：2025年 62亿美元
预测年份：2032年 128亿美元
复合年增长率 (%) 10.93%

简要说明定序试剂市场格局，重点在于技术差异、采购现况和平台主导的供应商动态。

定序试剂产业处于分子生物学创新与下游应用（包括诊断、治疗发现和环境基因组学）的关键交汇点。读取长度、通量和化学技术的进步正推动试剂需求从通用组分转向高度专业化、平台优化的配方。这种演变造就了充满活力的供应商格局，其中试剂品质、批间一致性以及酵素和标记化学相关的智慧财产权决定着实验室的采用率和性能。

学术界、临床实验室、受託研究机构和产业界的相关人员依赖稳定可靠的高纯度试剂供应，以支持那些对可重复性和合规性要求极高的实验。同时，定序平台的激增催生了多个平行的试剂生态系统，每个生态系统都有其独特的验证需求和支援服务。因此，买家在评估供应商时，不仅会考虑价格和供货情况，还会关注技术支援、验证数据以及与资讯学工作流程的整合。

综上所述，这些动态凸显了深入了解产品类型、特定应用需求和平台依赖的必要性。决策者面临的紧迫挑战是如何使采购和产品开发策略与现代定序工作流程的实际操作相契合，同时预见技术和政策方面的潜在变革。

技术进步、平台生态系统整合和供应链韧性如何重新定义试剂供应商的角色和产品策略

定序试剂市场正受到多种变革性因素的重塑，这些因素提高了对供应商应对力和产品特异性的要求。下一代和第三代测序技术的进步，对试剂提出了更高的要求，即需要能够支援更高保真度的合成、更宽的动态范围，并与日益自动化的文库製备流程相容。同时，RNA定序和总体基因体学应用的扩展，也推动了对低起始量样本、降解核酸和复杂环境基质优化的试剂的需求。

随着技术变革的推进，平台供应商正透过提供垂直整合的试剂组和认证项目，加深对生态系统的控制。这些项目虽然简化了终端用户的验证流程，但也为第三方供应商设置了障碍。这一趋势影响着新旧试剂参与企业，迫使新参与企业在与平台建立紧密伙伴关係和采取更广泛的跨平台相容策略之间做出选择。疫情期间的衝击暴露了依赖单一来源的关键酵素和高纯度缓衝液的脆弱性，促使人们开始采用双重采购和区域库存策略。

最后，监管监督和实验室认证要求与商业性压力融合，推动了试剂可追溯性和品质系统文件编制标准的提高。总而言之，这些变化正在将试剂供应商转变为策略合作伙伴，除了耗材之外，他们还提供技术服务、检验的工作流程和可靠的物流保障。

评估近期美国关税措施对试剂采购、供应链设计和供应商本地化策略的累积影响

美国新推出的进口关税为定序试剂生产商、经销商和终端用户带来了复杂的商业环境。关税调整会改变依赖进口原料、专用酵素和成品试剂套件的试剂生产商的成本结构，进而影响营运预算紧张的实验室的采购决策。在许多情况下，最直接的影响是重新评估筹资策略，寻找替代供应商，调整采购时间，或重组定价模式以应对成本上涨。

除了直接的成本压力外，关税还会促使企业采取更长期的结构性因应措施。供应商可能会加快关键零件的本地化进程，在关税更容易征收的地区寻求免收费用生产安排，或重新设计产品包装或零件以改变关税分类。此类调整通常涉及加强供应链文件的审核、优化关税编码，以及与海关当局沟通，在适用情况下寻求豁免和申诉。

实验室和采购机构正在透过扩展供应商风险评估标准和合格通讯协定来应对这一变化，将总到岸成本分析纳入考量，从而降低关税的影响。一些机构可能还会优先选择物流更方便或保质期更长的物流，以减少短期中断的影响。整体而言，关税主导的动态提升了供应商透明度、合约灵活性以及跨境运输可追溯性和合规性证明能力的重要性。

主导细分的关键洞察揭示了产品类型、应用需求、技术选择、终端用户期望和平台生态系统如何决定试剂策略。

对细分市场的细緻分析揭示了不同产品类型、应用、技术、最终用户和平台的需求驱动因素和要求。在各类产品中，适配器和标籤、缓衝液和溶液、标记试剂、核苷酸以及聚合酵素和酵素的品质规格和验证需求各不相同。特别是聚合酵素和酶，包括DNA聚合酵素、连接酶和逆转录酶，它们各自具有独特的稳定性特征和储存条件，这会影响物流和使用者操作流程。这些差异会影响库存计划和客户支援模式，因为依赖酵素的工作流程通常需要低温运输完整性和清晰的操作说明，以确保实验成功。

应用领域进一步影响试剂的选择标准。总体基因体学定序强调污染控制和能够适应不同样本基质的稳健萃取化学方法，而RNA定序则重视能够保护不稳定转录物并最大限度减少降解的试剂。标靶定序流程优先考虑能够实现多重定序的高特异性标记和接头系统，而全基因组定序则要求试剂能够在各种文库中实现均匀覆盖和最小偏差。这些应用层面的要求促使人们需要技术文件、检验的通讯协定以及（如适用）临床或监管部门的批准。

技术细分凸显了相容性方面的考量。新一代定序平台通常倾向于使用短读长定序化学试剂和针对高性能自动化优化的试剂组；桑格定序凭藉其成熟的试剂操作流程，在标靶验证领域占据一席之地；而第三代定序则需要针对长读长和单分子保真度定制的化学试剂。最终用户群体（包括学术研究机构、受託研究机构、医疗保健和诊断实验室以及製药和生物技术公司）的细分，使得他们对规模、文件和周转时间有着不同的期望。学术实验室可能优先考虑成本和灵活性，而诊断实验室则要求批次间性能可重复性以及符合监管要求的可追溯性。

平台特定的生态系统增加了复杂性。主要的仪器系列包括 Illumina、Oxford Nanopore、PacBio 和 Thermo Fisher，每个系列都支援平台特定的耗材和辅助设备。在这些系列中，子平台，例如 Illumina 的 MiSeq、NextSeq 和 NovaSeq；Oxford Nanopore 的 MinION 和 PromethION；PacBio 的 RS II 和 Sequel；以及 Thermo Fisher 的 Ion Torrent 和 QuantStudio，都需要特定的试剂规格、验证步骤和使用者培训。供应商如果能够将产品开发和验证与平台 API 和服务网路相匹配，就可以缩短客户的资格确认週期，并在平台封闭的环境中提高产品的采用率。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和采购行为将影响供应商的定位和营运重点。

美洲、欧洲、中东和非洲以及亚太地区的区域动态正在影响采购行为、监管预期和供应链架构。美洲拥有高度集中的研究机构、生物技术中心和临床实验室，支撑着一个成熟的试剂市场，该市场重视快速交货、技术支援以及与高性能自动化系统的整合。临床环境中的法律规范和认证流程奖励供应商透过提供详细的文件、品管证据和检验的工作流程来加快产品应用。

欧洲、中东和非洲医疗基础设施和研发能力的差异导致采购方的优先事项各不相同。西方市场通常优先考虑监管合规性、供应商认证和永续性，而新兴市场则优先考虑价格和物流便利性。此外，欧洲、中东和非洲复杂的跨境供应法规和关税制度也会影响交货前置作业时间和库存计画。

亚太地区定序仪的快速部署与强大的试剂和组件生产基地相结合。亚太地区的实验室通常寻求本地化的配方专业知识、快速的技术响应和具有竞争力的价格，而区域製造商和契约製造製造商则提供了近岸外包和经济高效的采购机会。所有地区的优先事项都是可预测的供应、符合当地法规和进口要求，以及供应商提供针对当地应用情境的技术培训和应用支援的能力。

领先的试剂供应商如何利用创新、平台伙伴关係和供应链韧性来加强其市场地位和客户价值提案

领先的试剂供应商透过技术创新、与平台供应商的策略伙伴关係以及超越产品交付的增强型服务来实现差异化。对专有酶工程、稳定化化学和标记技术的投资使供应商能够弥补性能差距，并支援低起始量RNA测序和复杂元基因组文库等新兴应用。同时，与仪器製造商的合作以及参与检验专案有助于供应商获得首选供应商地位，并简化客户采用流程。

除了产品研发之外，企业还透过多元化製造地、确保替代原料供应以及实施更严格的品管系统来增强供应链的韧性。这些营运措施降低了中断风险，并有助于履行有关供货的合约承诺。客户的能力也不断提升，许多供应商提供技术培训、工作流程优化服务以及客製化试剂组，这些试剂盒包含试剂、经过检验的方案和数据分析指导。

竞争动态有利于那些能够将雄厚的科学知识、透明的监管文件和灵活的物流模式结合的企业。策略併购和联盟仍然是获取互补技术、拓展产品系列以及加速进入新的应用领域和地理的有效途径。对于采购者而言，这意味着其关注点将从单纯的单价转向评估供应商在研发、製造和售后支援等方面的能力。

为试剂生产商和采购负责人提供切实可行的建议，以提高韧性、加快验证速度并透过技术服务产品实现差异化。

为了因应不断变化的技术需求和地缘政治压力，产业领导者应优先采取一系列切实有效、影响深远的行动，将科学研究绩效与营运韧性结合。首先，建立多源资讯来源框架，对关键酵素和缓衝液的替代生产商进行资格认证，并透过标准化的检验通讯协定证明其等效性。这可以降低单一供应商失效的风险，并在合约谈判中增强谈判筹码。

第二，增加与平台供应商和临床实验室的技术合作力度，共同开发经过验证的试剂组和认证途径，以缩短推广週期。此类合作可包括交叉检验测试，以确保不同仪器型号间结果的可重复性；联合品牌培训材料；以及联合技术支援。第三，优化供应链设计，例如在地化库存时效性试剂、实施冗余低温运输以及采用精通关税的物流策略，以降低进口成本波动。

第四，我们透过采用国际认可的品管标准、加强原材料可追溯性以及全面管理稳定性数据和批次放行数据，来强化监管和品质文件记录。第五，我们优先提供以客户为中心的服务，例如承包文库製备试剂套件、易于自动化的格式以及按需技术支持，并在价格之外提供差异化服务。这些措施共同帮助机构保持营运连续性，维护实验室工作流程中的科学诚信，并在不断变化的市场环境中保持竞争优势。

一种结合主要相关人员访谈、技术文献综述和供应链图谱的调查方法，旨在获得关于试剂市场的有效且可操作的见解。

本分析的调查方法结合了主要相关人员访谈、技术文献综述和供应链图谱分析，以确保得出可靠且有理有据的结论。主要研究包括对实验室主任、采购负责人、平台专家和试剂研发科学家进行结构化访谈，以了解试剂性能、验证困难和采购限制等方面的实际需求。此外，也咨询了资讯学和品质保证专家，以了解文件和监管方面的要求。

二手研究透过同行评审的出版物、验证研究和製造商文檔，证实了定序化学和平台要求的技术趋势。供应链图谱识别了原材料采购、製造外包关係和低温运输依赖性中的关键节点，为风险评估和缓解策略提供了基础。整个研究过程中采用了数据三角测量和交叉检验，以协调不同相关人员群体的观点，并揭示供应商行为和买方期望中的一致模式。

调查方法包括不同机构间实验室层级的差异以及平台特异性试剂生态系的演化。在主要研究中，我们遵守了伦理考量和保密措施，并保持了方法学的透明度，以便在可行的情况下重复关键分析步骤。

战略要务综合分析表明，试剂品质、平台验证和供应链敏捷性如何共同决定营运韧性和推广轨迹。

综合证据表明，试剂生态系统正变得日益专业化、服务化，并且对技术和政策的变动更为敏感。能够提供高品质、平台验证的试剂，同时提供强大的检验支援和稳健的供应链的研究公司，更有能力满足科学研究、临床和工业终端用户的多样化需求。平台特定的生态系统和应用主导的需求正迫使试剂供应商采取差异化的产品策略，并投资于认证和文件能力建设，以解决监管和可重复性方面的问题。

同时，地缘政治发展和关税调整凸显了供应链敏捷性和关税敏感型物流的重要性，促使供应商和实验室重新思考筹资策略和库存管理。最终结果是，市场环境要求科学研究卓越性必须与营运可靠性和商业性弹性相符。价值链上相关人员的首要任务是将技术诀窍转化为可复製、检验的解决方案，以便无论区域或政策相关干扰如何，都能可靠地大规模部署。

展望未来，平台创新、应用多样化和供应链韧性之间的相互作用可能会塑造定序试剂领域的竞争动态和采用模式。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 肿瘤学研究中对单细胞定序试剂日益增长的需求推动了试剂创新。
  • 采用长读长定序技术来改善基因组组装和结构变异检测
  • 加速开发用于法医学和临床应用的低投入量和降解样品试剂
  • 在定序工作流程中更充分地整合自动化技术，以实现试剂标准化并提高通量。
  • 可携式孔测序试剂的研发，旨在实现现场病原体检测和环境监测。
  • 结合表观表观基因和转录组学分析的多组体学定序试剂套件在生物标记发现的应用日益广泛
  • 经济高效的条码和多重标记试剂的出现，促进了大规模人群基因组学研究。
  • 针对罕见疾病诊断的标靶定序技术的创新提高了试剂的特异性和效率
  • 开发无需逆转录即可进行全面转录组分析的直接RNA定序试剂

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 依产品类型分類的定序试剂市场

  • 适配器和标籤
  • 缓衝液和溶液
  • 标记试剂
  • 核苷酸
  • 聚合酵素和酶
    • DNA聚合酵素
    • 连接酶
    • 逆转录酶

第九章 依应用分類的定序试剂市场

  • 总体基因体学体定序
  • RNA定序
  • 目标序列
  • 全基因组序列分析

第十章 依技术分類的定序试剂市场

  • 下一代定序
  • 桑格定序
  • 第三代定序

第十一章 依最终用户分類的定序试剂市场

  • 学术研究
  • 合约研究组织
  • 医疗保健和诊断实验室
  • 製药和生物技术公司

第十二章 定序试剂市场（依平台划分）

  • Illumina
    • Miseq
    • Nextseq
    • Novaseq
  • Oxford Nanopore
    • Minion
    • Promethion
  • Pacbio
    • Rs Ii
    • Sequel
  • Thermo Fisher
    • Ion Torrent
    • Quantstudio

第十三章 各地区定序试剂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 定序试剂市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国定序试剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • QIAGEN NV
    • MGI Tech Co. Ltd.
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies plc
    • Takara Bio Inc.
    • New England Biolabs, Inc.
Product Code: MRR-A26E0E57453C

The Sequencing Reagents Market is projected to grow by USD 12.80 billion at a CAGR of 10.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.58 billion
Estimated Year [2025] USD 6.20 billion
Forecast Year [2032] USD 12.80 billion
CAGR (%) 10.93%

A concise orientation to the sequencing reagents landscape highlighting technological differentiation, procurement realities, and platform-driven supplier dynamics

The sequencing reagents sector occupies a critical junction between molecular biology innovation and downstream applications that power diagnostics, therapeutics discovery, and environmental genomics. Technological advances in read length, throughput, and chemistry have shifted reagent requirements from general-purpose components to highly specialized, platform-optimized formulations. This evolution has produced a dynamic supplier landscape where reagent quality, lot-to-lot consistency, and intellectual property around enzymes and labeling chemistries determine adoption and performance across laboratories.

Stakeholders across academia, clinical laboratories, contract research organizations, and industry rely on a predictable supply of high-purity reagents to support experiments that demand reproducibility and regulatory compliance. At the same time, the proliferation of sequencing platforms has created parallel reagent ecosystems, each with distinct validation needs and support services. As a result, buyers now evaluate vendors not only on price and availability but also on technical support, validation data, and integration with informatics workflows.

Taken together, these dynamics underscore the need for a nuanced understanding of product categories, application-specific demands, and platform dependencies. For decision-makers, the immediate imperative is to align procurement and product development strategies with the operational realities of modern sequencing workflows while anticipating both technological and policy-driven disruptions.

How technological advances, platform ecosystem consolidation, and supply chain resilience imperatives are redefining reagent supplier roles and product strategies

The sequencing reagents landscape is being reshaped by several transformative forces that collectively raise the bar for supplier responsiveness and product specificity. Advances in next-generation and third-generation chemistries are demanding reagents that can support higher-fidelity synthesis, broader dynamic range, and compatibility with increasingly automated library-preparation workflows. Concurrently, the expansion of RNA sequencing and metagenomics applications has increased demand for reagents optimized for low-input samples, degraded nucleic acids, and complex environmental matrices.

Parallel to these technical shifts, platform vendors are deepening their ecosystem control by offering vertically integrated reagent kits and certification programs that simplify validation for end users while creating barriers for third-party suppliers. This trend has implications for new entrants and established reagent companies alike, who must decide between tight platform partnerships or broader cross-platform compatibility strategies. Supply chain resilience has become another defining variable; the pandemic-era disruptions exposed vulnerabilities in single-source dependencies for critical enzymes and high-purity buffers, prompting a wave of dual-sourcing and regional inventory strategies.

Finally, regulatory scrutiny and laboratory accreditation requirements are converging with commercial pressures to drive higher documentation standards around reagent traceability and quality systems. Collectively, these shifts are transforming reagent suppliers into strategic partners that offer technical service, validated workflows, and logistical reliability in addition to consumable products.

Assessing the cumulative effects of recent United States tariff actions on reagent sourcing, supply chain design, and supplier localization strategies

The introduction of new tariff measures affecting imports into the United States has created a complex operating environment for manufacturers, distributors, and end users of sequencing reagents. Tariff adjustments alter the cost structure for reagent producers that rely on imported raw materials, specialized enzymes, or finished kits, and they can influence procurement decisions across laboratories that face tighter operational budgets. In many cases, the immediate effect is a re-evaluation of sourcing strategies to identify alternative suppliers, shift purchasing timing, or absorb incremental costs through restructured price models.

Beyond direct cost pressures, tariffs can drive longer-term structural responses. Suppliers may accelerate efforts to localize production of critical components, pursue toll manufacturing arrangements within tariff-friendly jurisdictions, or redesign product packaging and components to alter customs classifications. These adaptations are often accompanied by increased diligence around supply chain documentation, tariff code optimization, and engagement with customs authorities to pursue exclusions or appeals where applicable.

Laboratories and procurement organizations respond by expanding qualification protocols to include supplier risk metrics and total landed cost analyses that factor in tariff exposure. Some institutions may prioritize reagents with simplified logistics or enhanced shelf life to buffer short-term disruptions. In the aggregate, tariff-driven dynamics increase the value of supplier transparency, contractual flexibility, and the capacity to demonstrate traceability and compliance across cross-border shipments.

Key segmentation-driven insights revealing how product categories, application demands, technology choices, end-user expectations, and platform ecosystems dictate reagent strategy

A granular view of segmentation reveals differentiated demand drivers and requirements across product types, applications, technologies, end users, and platforms. Within product type, adapters and tags, buffers and solutions, labeling reagents, nucleotides, and polymerases and enzymes each exhibit distinct quality specifications and validation needs; polymerases and enzymes in particular encompass DNA polymerases, ligases, and reverse transcriptases, each carrying unique stability profiles and storage conditions that affect logistics and user protocols. These distinctions inform inventory planning and customer support models because enzyme-dependent workflows often require cold-chain integrity and clear handling instructions to ensure experimental success.

Application domains further shape reagent selection criteria. Metagenomics sequencing places premium value on contamination controls and robust extraction chemistries capable of addressing diverse sample matrices, while RNA sequencing emphasizes reagents that preserve labile transcripts and minimize degradation. Targeted sequencing workflows prioritize high-specificity labeling and adapter systems that enable multiplexing, and whole genome sequencing demands reagents that support uniform coverage and minimal bias across extensive libraries. These application-level requirements drive demand for technical documentation, validated protocols, and certification for clinical or regulatory use where applicable.

Technology segmentation underscores compatibility considerations. Next-generation sequencing platforms often favor reagent kits optimized for short-read chemistries and high-throughput automation, Sanger sequencing retains a niche for targeted validation with long-established reagent conventions, and third-generation sequencing requires chemistries tailored for long reads and single-molecule fidelity. End-user segmentation-spanning academic research, contract research organizations, healthcare and diagnostic laboratories, and pharmaceutical and biotechnology companies-creates varying expectations for scale, documentation, and turnaround times; academic labs may prioritize cost and flexibility, whereas diagnostics labs demand reproducible lot-to-lot performance and regulatory-grade traceability.

Platform-specific ecosystems introduce another layer of complexity. Major instrument families include Illumina, Oxford Nanopore, PacBio, and Thermo Fisher, each supported by platform-tailored consumables and accessory instruments. Within those families, sub-platforms such as Illumina's MiSeq, NextSeq, and NovaSeq; Oxford Nanopore's MinION and PromethION; PacBio's RS II and Sequel; and Thermo Fisher's Ion Torrent and QuantStudio require specific reagent formats, validation steps, and user training. Suppliers that align product development and validation with platform APIs and service networks can shorten customer qualification cycles and increase adoption in platform-locked environments.

Regional dynamics and procurement behaviors across the Americas, Europe Middle East and Africa, and Asia-Pacific that drive supplier positioning and operational priorities

Regional dynamics shape procurement behaviors, regulatory expectations, and supply chain architectures across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, a concentration of research institutions, biotech hubs, and clinical laboratories supports a sophisticated reagent market that values rapid delivery, technical support, and integration with high-throughput automation. Regulatory frameworks and accreditation processes in clinical settings further incentivize suppliers to provide detailed documentation, quality management evidence, and validated workflows to facilitate adoption.

Across Europe, the Middle East and Africa, heterogeneity in healthcare infrastructure and research capacity results in divergent buyer priorities. Western European markets typically emphasize regulatory conformity, supplier certifications, and sustainability considerations, whereas emerging markets focus on affordability and logistical accessibility. The broader EMEA region also exhibits complex cross-border supply considerations and customs regimes that affect lead times and inventory planning.

The Asia-Pacific region combines rapidly expanding sequencing adoption with a strong manufacturing base for reagents and components. Laboratories in APAC often seek local-formulation expertise, rapid technical response, and competitive pricing, while regional manufacturers and contract producers offer opportunities for nearshoring and cost-effective sourcing. Across all regions, the shared priorities are predictable supply, compliance with local regulatory and import requirements, and the ability of suppliers to provide technical training and application support tailored to regional use cases.

How top reagent suppliers are leveraging innovation, platform partnerships, and supply chain resilience to strengthen market position and customer value propositions

Leading reagent suppliers are differentiating through a combination of technical innovation, strategic partnerships with platform vendors, and enhanced service offerings that go beyond product delivery. Investments in proprietary enzyme engineering, stabilization chemistries, and labeling technologies enable suppliers to address performance gaps and support emerging applications such as low-input RNA sequencing and complex metagenomic libraries. At the same time, collaboration with instrument manufacturers and participation in validation programs creates pathways for preferred supplier status and streamlined customer onboarding.

Beyond product R&D, companies are strengthening supply chain resilience by diversifying manufacturing footprints, qualifying alternate raw material sources, and implementing stricter quality control regimes. These operational measures reduce the risk of disruption and support contractual commitments for availability. Customer-facing capabilities are also expanding, with many suppliers offering technical training, workflow optimization services, and customized reagent kits that bundle reagents with validated protocols and data analysis guidance.

Competitive dynamics favor organizations that can combine robust scientific IP with transparent regulatory documentation and responsive logistical models. Strategic M&A and alliances continue to be tools for accessing complementary technologies, broadening product portfolios, and accelerating entrance into new application areas or geographic regions. For buyers, these trends mean an increased emphasis on evaluating supplier capability across R&D, manufacturing, and post-sale support rather than focusing solely on unit pricing.

Actionable recommendations enabling reagent manufacturers and procurement leaders to enhance resilience, accelerate validation, and differentiate through technical service offerings

To navigate a landscape of evolving technological requirements and geopolitical pressures, industry leaders should prioritize a set of pragmatic, high-impact actions that align operational resilience with scientific performance. First, establish multi-source procurement frameworks that qualify alternative manufacturers for critical enzymes and buffers while documenting equivalency through standardized validation protocols. This reduces exposure to single-source disruptions and provides leverage during contract negotiations.

Second, invest in close technical partnerships with platform vendors and clinical laboratories to co-develop validated reagent kits and certification pathways that shorten adoption cycles. Such collaborations can include cross-validation studies, co-branded training materials, and joint technical support to ensure reproducible outcomes across instrument generations. Third, optimize supply chain design by localizing inventory for time-sensitive reagents, implementing cold-chain redundancies, and employing tariff-savvy logistics strategies to mitigate import-related cost volatility.

Fourth, strengthen regulatory and quality documentation by adopting internationally recognized quality management standards, enhancing traceability of raw materials, and maintaining thorough stability and lot-release data. Fifth, prioritize customer-centric services such as turnkey library preparation kits, automation-friendly formats, and on-demand technical assistance to differentiate offerings beyond price. Collectively, these actions will help organizations maintain operational continuity, preserve scientific integrity in laboratory workflows, and sustain competitive advantage amid shifting market conditions.

Methodological framework combining primary stakeholder interviews, technical literature synthesis, and supply chain mapping to produce validated and actionable reagent market insights

The research methodology underpinning this analysis combined primary stakeholder engagements, technical literature synthesis, and supply chain mapping to ensure robust and defensible insights. Primary research included structured interviews with laboratory directors, procurement leads, platform specialists, and reagent development scientists to capture real-world priorities around reagent performance, validation hurdles, and sourcing constraints. These conversations were supplemented by expert consultations with informatics and quality assurance professionals to understand documentation and regulatory expectations.

Secondary research drew on peer-reviewed publications, validation studies, and manufacturer documentation to corroborate technical trends in sequencing chemistry and platform requirements. Supply chain mapping identified critical nodes for raw material procurement, contract manufacturing relationships, and cold-chain dependencies, which informed risk assessments and mitigation strategies. Data triangulation and cross-validation were employed throughout to reconcile perspectives from different stakeholder groups and to surface consistent patterns in supplier behavior and buyer expectations.

Limitations of the methodology include variability in lab-level practices across institutions and the evolving nature of platform-specific reagent ecosystems, which means some operational nuances may shift as new chemistries and instrument versions are introduced. Ethical considerations and confidentiality safeguards were observed during primary engagements, and methodological transparency was maintained to allow replication of key analytical steps where feasible.

Synthesis of strategic imperatives showing how reagent quality, platform validation, and supply chain agility jointly determine operational resilience and adoption trajectories

The collective evidence points to a reagent ecosystem that is increasingly specialized, service-oriented, and sensitive to both technological and policy-driven disruptions. Suppliers that can deliver high-quality, platform-validated reagents while offering robust technical support and resilient supply chains will be better positioned to meet the diverse needs of research, clinical, and industrial end users. Platform-specific ecosystems and application-driven requirements are compelling reagent providers to adopt differentiated product strategies and to invest in certification and documentation capabilities that address regulatory and reproducibility concerns.

At the same time, geopolitical developments and tariff realignments have elevated the importance of supply chain agility and tariff-aware logistics, prompting both suppliers and laboratories to reassess sourcing strategies and inventory management. The net effect is a market environment where scientific excellence must be matched by operational reliability and commercial flexibility. For stakeholders across the value chain, the priority is to convert technical know-how into reproducible, validated solutions that can be reliably deployed at scale, regardless of regional or policy-related disruptions.

Looking forward, the interplay between platform innovation, application diversification, and supply chain resilience will continue to shape competitive dynamics and adoption patterns within the sequencing reagents domain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expanding demand for single-cell sequencing reagents in oncology research driving reagent innovation
  • 5.2. Adoption of long-read sequencing chemistry for improved genome assembly and structural variant detection
  • 5.3. Accelerating development of low-input and degraded sample reagents for forensic and clinical applications
  • 5.4. Increased integration of automation in sequencing workflows boosting reagent standardization and throughput
  • 5.5. Growth of portable nanopore sequencing reagents enabling field-based pathogen detection and environmental monitoring
  • 5.6. Rising adoption of multiomic sequencing kits combining epigenomic and transcriptomic analyses in biomarker discovery
  • 5.7. Emergence of cost-effective barcoding and multiplexing reagents to facilitate large-scale population genomics studies
  • 5.8. Innovation in targeted sequencing panels for rare disease diagnostics enhancing reagent specificity and efficiency
  • 5.9. Development of direct RNA sequencing reagents for comprehensive transcriptome profiling without reverse transcription

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sequencing Reagents Market, by Product Type

  • 8.1. Adapters And Tags
  • 8.2. Buffers And Solutions
  • 8.3. Labeling Reagents
  • 8.4. Nucleotides
  • 8.5. Polymerases And Enzymes
    • 8.5.1. Dna Polymerases
    • 8.5.2. Ligases
    • 8.5.3. Reverse Transcriptases

9. Sequencing Reagents Market, by Application

  • 9.1. Metagenomics Sequencing
  • 9.2. Rna Sequencing
  • 9.3. Targeted Sequencing
  • 9.4. Whole Genome Sequencing

10. Sequencing Reagents Market, by Technology

  • 10.1. Next-Generation Sequencing
  • 10.2. Sanger Sequencing
  • 10.3. Third-Generation Sequencing

11. Sequencing Reagents Market, by End User

  • 11.1. Academic Research
  • 11.2. Contract Research Organizations
  • 11.3. Healthcare And Diagnostic Laboratories
  • 11.4. Pharmaceutical And Biotechnology Companies

12. Sequencing Reagents Market, by Platform

  • 12.1. Illumina
    • 12.1.1. Miseq
    • 12.1.2. Nextseq
    • 12.1.3. Novaseq
  • 12.2. Oxford Nanopore
    • 12.2.1. Minion
    • 12.2.2. Promethion
  • 12.3. Pacbio
    • 12.3.1. Rs Ii
    • 12.3.2. Sequel
  • 12.4. Thermo Fisher
    • 12.4.1. Ion Torrent
    • 12.4.2. Quantstudio

13. Sequencing Reagents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sequencing Reagents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sequencing Reagents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Illumina, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. F. Hoffmann-La Roche Ltd.
    • 16.3.4. Danaher Corporation
    • 16.3.5. QIAGEN N.V.
    • 16.3.6. MGI Tech Co. Ltd.
    • 16.3.7. Pacific Biosciences of California, Inc.
    • 16.3.8. Oxford Nanopore Technologies plc
    • 16.3.9. Takara Bio Inc.
    • 16.3.10. New England Biolabs, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SEQUENCING REAGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PLAT